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scaffolds were placed individually in a custom made multiple chamber
bioreactor which allowed application of physiologically relevant PHP on
multiple independent test specimens simultaneously. PHP was applied
incrementally, starting from 0.1 MPa to 5 MPa. Each load was applied to
the cell-scaffold construct for 30 minutes per day, 5 days per week. The
loading regime changed incrementally every two weeks for 10 weeks. DNA
and GAG production was evaluated at the end of each loading regime. Cell
viability was assessed by using a live-dead cell staining kit and measured
via confocal microscope. Selected samples were examined by scanning
electronic microscopy (SEM). Mechanical properties of the constructs were
determined by measuring the compressive modulus using an unconﬁned
uniaxial compression test at 8 and 10 weeks.
Results: Cell survival was between 70%-95% over 10 weeks culture period.
The results showed that GAG production increased with time although
variation among the three donors was observed (Fig. 1). There was a trend
toward higher GAGs synthesis in the PHP group for two donors when
measured by total GAG production per microgram DNA (Fig. 2). Taking
together both cumulated GAG content and synthesis from 2 donors, GAGs
synthesis was signiﬁcant greater at 2 and 4 weeks in the PHP group than
the control group (p<0.05). SEM shown that there were higher densities of
tissue formed in PHP group than the controls (Fig. 3). Similar mechanical
properties were observed in both groups.
Figure 3
Discussion and Conclusions: GAG production increase with time when
PHP was applied incrementally over 10 week period. There appears to
be signiﬁcant enhancement of tissue induction and chondrogenesis within
synthetic scaffolds when engineered tissue is subject to PHP at the early
stage of the culture. Because the neo-tissue is so fragile and cannot endure
high mechanical load, the lower load should be preferred. It is believed
this experimental model is more representative of conditions experienced
in vivo by scaffold implants over the early weeks post surgery. The main
outcome of this study will inform surgery on the optimal post-operative
rehabilitation regime. However, PHP did not inﬂuence the mechanical
properties of engineered tissue over the experimental period. Additional
studies need to be performed to optimise the time of application of PHP
and other associated mechanical stimuli.
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Purpose: Mesenchymal stem cells (MSCs) are considered one of the
promising biologics to treat joint diseases. The successful clinical usage of
these cells lies in the eﬃcacy of delivering cells to the location targeted
for treatment and maintaining these cells in a viable and functional form
after implantation. Among all the solid and viscous carriers investigated
so far, hydrogels have the advantage of delivering and releasing cells in
a controlled manner. This study investigates cellular response of human
MSCs to a novel, in situ crosslinking, hyaluronan (HyA) based hydrogel.
It was hypothesized the HyA hydrogel would support cell survival for a
period of time at high cell densities.
Methods: Three hyaluronan hydrogel formulations (HyA-1, HyA-2, HyA-
3) were tested, which differed in their crosslinking chemistry, gelation
time and buffer system. Agarose hydrogel was used as control. hMSCs
(p3) were expanded in DMEM/10%FBS/1% antibiotics. After trypsinization,
cells were suspended in the hydrogel at the desired ﬁnal concentration.
Cell/hydrogel mixture was then aliquoted into 48-well plates and allowed
to crosslink before fresh medium was added. The cell/hydrogel constructs
were cultured up to 14 days. Viability of encapsulated hMSCs was assessed
using a LIVE/DEAD assay. Cell proliferation was determined using Quan-iT
PicoGreen dsDNA assay. All quantitative data were expressed as Mean±SD.
Two-way ANOVA and post-hoc Tukey’s HSD testing were performed using
SYSTAT with P<0.05 considered signiﬁcant.
Results: All HyA hydrogels were able to incorporate hMSCs at a low
(1×106/ml) and a high (10×106/ml) density. Encapsulation of cells did not
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alter the normal gelation time of the HyA hydrogels. In contrast to the stiff
agarose hydrogel, HyA hydrogels were relatively soft and slightly sticky.
In all hydrogel constructs, cells appeared spherical and more than 70% of
cells remained viable at 24 hrs after encapsulation, regardless of seeding
density (Fig. 1). Long term cell viability and proliferation were analyzed in
HyA-2 constructs at two cell densities. The viability of encapsulated cells
remained above 80-90% at low density, while it decreased to 60% at high
density over the 14 days culture duration (Fig. 2). No cell proliferation
was observed in the cell/HyA-2 constructs (Fig. 3). The number of hMSCs
present in the HyA-2 hydrogel remained unchanged with culture duration
at the lower seeding density, but decreased signiﬁcantly at higher density
(Fig. 3).
Figure 1. Viability of encapsulated hMCSs in four different hydrogels at two seeding den-
sities.
Figure 2. Viability of encapsulated hMCSs in HyA-2 at two seeding densities.
Figure 3. Proliferation of encapsulated hMSCs in HyA-2 during 14 days culture.
Conclusions: In this study, we evaluated the cellular response of hM-
SCs to three novel hyaluronan hydrogel formulations. Our initial results
demonstrated that the HyA hydrogels have the capacity to encapsulate
adult human stem cells without altering the intrinsic gelation time. All
hydrogels supported cell survival over an extended culturing period. Stem
cells regained their 3-D phenotype and appeared to switch from the
proliferating to differentiation state. The in situ, crosslinking capacity of
these HyA hydrogels may allow for the preparation of cell/gel mixture ex
vivo for subsequent delivery to a desired location where the crosslinking
process can be completed. Future studies will include evaluation of cell
differentiation in the hydrogel, secretion of cytokines from encapsulated
cells, and cell release from the hydrogel construct. Results from these
studies will shed light on the suitability of these HyA hydrogels as a cell
delivery carrier into targeted disease sites or tissue repair applications.
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Purpose: Mesenchymal Stem cells (MSCs) are useful multipotent stem
cells that are found in many tissues. Due to important ethic and safety
limitations for clinical use of pluripotent embryonic stem cells, MSCs are
predominantly used in human clinical assays. While MSCs can usually be
isolated from adults via bone marrow aspiration (BM-MSCs), MSCs derived
from the discarded umbilical cord, more precisely from Wharton’s jelly,
offer a low-cost and pain-free collection method of MSCs that may be cryo-
genically stored. Moreover, the feature of Wharton’s jelly MSCs (WJ-MSCs)
is intermediate between embryonic and adult MSCs. Brieﬂy, compared to
adult stem cells, they show an increased telomerase activity and compared
to embryonic stem cells, they have a lower rate of DNA lesions after cell
division. These properties are extremely favorable for considering them
for tissue engineering purpose. However, culture expansion of MSCs is a
prerequisite, since high absolute numbers of stem cells are required to
reach a clinical dose. Thus, the aim of this study was to characterize these
WJ-MSCs during monolayer expansion (from P0 to P10), under normoxia
or hypoxia conditions.
Methods: With the consent of the parents, fresh human umbilical cords
were obtained from full-term births, aseptically stored in sterile saline and
processed within 6 hours from partum to obtain the WJ-MSCs. Individual
UC components were dissected, diced into 1-2 mm3 fragments, and aligned
in explant cultures from which migrating cells were isolated by scraping
until reaching P10 in both normoxia and hypoxia cultures. Stem cells were
expanded using α-MEM 10% fetal calf serum (FCS) based media. For each
culture conditions, characterization was performed, at each passage, at two
levels: cellular level (cell morphology, immunophenotyping) and functional
level (differentiation potential and metabolic activity).
Results: We found that normoxia or hypoxia conditions inﬂuenced
metabolic activity of MSCs and population doubling time. Moreover,
whatever culture conditions, we observed, at early passages, modiﬁcations
of cell morphology suggesting the possible presence of cellular subpopu-
lations. Using ﬂow cytometric analysis, our data revealed that WJ-MSCs
express matrix receptors (CD44, CD166, CD90, CD271) and integrin markers
(CD29) but not hematopoietic lineage markers (CD34, CD45, HLA-class II).
Interestingly, these cells also express signiﬁcant amounts of mesenchy-
mal stem cell markers (SH2, SH3). Finally, individual WJ-MSCs could be
selectively differentiated into osteoblasts, chondrocytes, and adipocytes.
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Purpose: Most efforts performed to repair injuries of the articular cartilage
focus on the limitations of this tissue to heal injuries and how to promote
vascularization. A current challenge is to avoid generation of a ﬁbro
cartilaginous tissue that does not mimic hyaline articular cartilage. The
transplantation of mesenchymal stem cells (MSCs) has been suggested as
an alternative therapeutic approach for treatment of cartilage defects.The
aim of this study was to evaluate the effects of both N- and C-terminal
fragments of PTHrP to promote chondrogenesis using BM-MSCs cultured
on pure equine type I collagen supports.
Methods: MSCs were isolated from human BM stroma and were expanded
in monolayer cultures. BM-MSCs were characterized by ﬂow cytometry
using hematopoietic and MSC markers. At the 3-4th passage, BM-MSCs
were cultured on 1×1cm2 collagen supports, pre-treated or not with PTHrP
